Dec 14, 2010 16:05 Newly Published Study Finds High Prevalence of BRCA Mutations in Breast Carcinoma in Situ (CIS)
Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that an article entitled "Prevalence of BRCA1 and BRCA2 Mutations In Women With Carcinoma In Situ of the Breast Referred for Genetic Testing" will appear in the December 2010 issue of the journal Cancer Prevention Research. The study demonstrated that BRACAnalysis(r) testing of at risk women with breast carcinoma in situ may provide valuable information to guide the physician's medical and surgical strategies for their patients. continued...
--------------------------------------------------------------------------------
Dec 14, 2010 16:05 Tufco Technologies, Inc. Announces Fiscal Year 2010 Fourth Quarter and Fiscal Year 2010 Results; Comments on Outlook
Tufco Technologies, Inc. (Nasdaq:TFCO), a leading provider of branded contract wet and dry wipes converting in North America and a leader in specialty printing services and business imaging products, today announced that for the fourth quarter of fiscal year 2010, sales were $25,342,000, an increase of 15% from the fourth quarter of fiscal year 2009. For fiscal year 2010, sales were $90,614,000, an increase of 4% from fiscal year 2009 sales. Net income per diluted share for the fourth quarter of fiscal 2010 was $0.01 compared to $0.04 net loss per diluted share for the fourth quarter of fiscal 2009. For fiscal year 2010, net loss was $0.10 per diluted share, compared to net loss of $0.20 per diluted share for fiscal year 2009. continued...